# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Wells Fargo analyst James Feldman maintains National Health Investors (NYSE:NHI) with a Overweight and raises the price targ...
National Health Investors (NYSE:NHI) reported quarterly earnings of $1.12 per share which beat the analyst consensus estimate o...
Truist Securities analyst Michael Lewis maintains National Health Investors (NYSE:NHI) with a Hold and raises the price targ...
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often com...
Wedbush analyst Richard Anderson maintains National Health Investors (NYSE:NHI) with a Outperform and raises the price targe...
BMO Capital Markets upgrades National Health Investors to Outperform, citing potential for multiple expansions, SHOP growth, an...